Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Scios and Janssen to copromote Risperdal

May 18, 1998

European Commission approves Novartis' Exelon

May 18, 1998

Ondansetron suppresses spontaneous sleep apnea in rats

May 18, 1998

Novel isoquinolines prepared at Snow Brand Milk Products inhibit neuronal cell death

May 15, 1998

TheraTech and Astra announce collaborative development of new pain medication

May 14, 1998

Pharmacokinetic profile of GTS-21 studied in rats after parenteral, oral dosing

May 14, 1998

Myotrophin declared "potentially approvable" by FDA

May 14, 1998

Phase II clinical trial initiated for Neotrofin

May 14, 1998

Phase I clinical trial of novel analgesic to begin in Sweden

May 13, 1998

Phase III trials in progress for HMR antipsychotic agent

May 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...